These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5555849)

  • 1. Alternate-day prednisone therapy for pemphigus vulgaris. Preliminary report.
    Rabhan NB; Kopf AW
    Arch Dermatol; 1971 Jun; 103(6):615-22. PubMed ID: 5555849
    [No Abstract]   [Full Text] [Related]  

  • 2. Methotrexate and prednisone in pemphigus vulgaris. Therapeutic results obtained in 36 patients between 1961 and 1970.
    Lever WF
    Arch Dermatol; 1972 Oct; 106(4):491-7. PubMed ID: 4562487
    [No Abstract]   [Full Text] [Related]  

  • 3. Alternate-day prednisone therapy. Evaluation of delayed hypersensitivity responses, control of disease and steroid side effects.
    MacGregor RR; Sheagren JN; Lipsett MB; Wolff SM
    N Engl J Med; 1969 Jun; 280(26):1427-31. PubMed ID: 4306760
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
    Werth VP
    Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternate-day corticosteroid regimen.
    Haim S; Benderly A; Shafrir A; Levy J
    Dermatologica; 1971; 142(3):171-6. PubMed ID: 5112615
    [No Abstract]   [Full Text] [Related]  

  • 6. An alternate-day corticosteroid regimen for pemphigus vulgaris. A 13-year prospective study.
    Chaidemenos GCh; Mourellou O; Koussidou T; Tsatsou F
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1386-91. PubMed ID: 17958846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.
    Heaphy MR; Albrecht J; Werth VP
    Arch Dermatol; 2005 Jun; 141(6):699-702. PubMed ID: 15967915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood pemphigus treated with gold.
    Paltzik RL; Laude TA
    Arch Dermatol; 1978 May; 114(5):768-9. PubMed ID: 348118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of pemphigus vulgaris by azathioprine and low doses of prednisone (Lever scheme)].
    Benoit Corven C; Carvalho P; Prost C; Verret JL; Saiag P; Noblesse I; Bedane C; Chosidow O; Young P; Roujeau JC; Joly P
    Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):13-5. PubMed ID: 12605150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of pemphigus vulgaris with methotrexate.
    Lever WF; Goldberg HS
    Arch Dermatol; 1969 Jul; 100(1):70-8. PubMed ID: 5822360
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclophosphamide in the treatment of pemphigus vulgaris and bullous pemphigoid.
    Krain LS; Landau JW; Newcomer VD
    Arch Dermatol; 1972 Nov; 106(5):657-61. PubMed ID: 4635797
    [No Abstract]   [Full Text] [Related]  

  • 12. Estimation of prednisone intake in pemphigus vulgaris patients with the use of simple laboratory methods.
    Segal R; Maayan R; Kaufman H; Feuerman EJ
    J Am Acad Dermatol; 1987 Oct; 17(4):612-5. PubMed ID: 3668007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of cyclosporin in the treatment of pemphigus vulgaris. Apropos of 3 cases].
    Castro-Salomó A; Porcel JM; Ordi J; Martínez-Costa X; Vilardell M; Vidal J
    Med Clin (Barc); 1991 Apr; 96(16):619-20. PubMed ID: 2051832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive therapy of pemphigus vulgaris complicated by Nocardia pneumonia. Gold as an alternate therapy.
    Murdock DK; Lookingbill DP
    Arch Dermatol; 1990 Jan; 126(1):27-8. PubMed ID: 2105086
    [No Abstract]   [Full Text] [Related]  

  • 15. Disseminated superficial porokeratosis in patients with pemphigus vulgaris treated with steroids.
    Feuerman EJ; Sandbank M
    Acta Derm Venereol Suppl (Stockh); 1979; 59(85):59-61. PubMed ID: 294099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycoplasma-like forms and immunofluorescent antibodies in cytoplasm and intercellular spaces of rete malpighii in pemphigus vulgaris and pemphigus vegetans.
    Grace AW
    Acta Cytol; 1969 Mar; 13(3):169-77. PubMed ID: 4890431
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell-mediated immunity in patients with less than pemphigus vulgaris greater than before, during and after prolonged treatment with steroids.
    Shohat B; David M; Feuerman EJ
    Biomedicine; 1981 Jul; 35(3):101-3. PubMed ID: 6974011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenocortical responsiveness after alternate-day corticosteroid therapy.
    Ackerman GL; Nolsn CM
    N Engl J Med; 1968 Feb; 278(8):405-9. PubMed ID: 5636662
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hypophysoadrenal effects of prolonged corticotherapy in small doses in asthmatic patients].
    Magnenat G; Cruchaud S; Ruedi B
    Schweiz Med Wochenschr; 1972 Jun; 102(23):804-9. PubMed ID: 4338343
    [No Abstract]   [Full Text] [Related]  

  • 20. [Post-mortem evaluation in endemic pemphigus foliaceus and pemphigus vulgaris].
    Aki HE; Sotto MN; Sampaio SA
    Med Cutan Ibero Lat Am; 1984; 12(2):151-7. PubMed ID: 6374324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.